Chengdu Kanghong Pharmaceutical Group Co., Ltd
Chengdu Kanghong Pharmaceutical Group Co., Ltd., commonly referred to as Kanghong, is a leading player in the pharmaceutical industry, headquartered in Chengdu, China. Established in 1998, the company has made significant strides in the development and production of innovative medical products, particularly in the fields of ophthalmology and oncology. Kanghong's core offerings include a range of high-quality pharmaceuticals and medical devices, distinguished by their commitment to research and development. The company has achieved notable market recognition, positioning itself as a trusted provider in both domestic and international markets. With a focus on enhancing patient care, Kanghong continues to expand its operational footprint, contributing to advancements in healthcare solutions.
DitchCarbon Score
How does Chengdu Kanghong Pharmaceutical Group Co., Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Chengdu Kanghong Pharmaceutical Group Co., Ltd's score of 22 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Chengdu Kanghong Pharmaceutical Group Co., Ltd's reported carbon emissions
Chengdu Kanghong Pharmaceutical Group Co., Ltd, headquartered in China, currently does not have publicly available data regarding its carbon emissions. As such, there are no specific figures to report on their Scope 1, 2, or 3 emissions. Additionally, the company has not outlined any formal reduction targets or commitments to climate initiatives, which limits the ability to assess their environmental impact or sustainability efforts. In the context of the pharmaceutical industry, companies are increasingly expected to adopt robust climate strategies and transparency in emissions reporting. However, without concrete data or commitments, it is challenging to evaluate Chengdu Kanghong Pharmaceutical Group's position on climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Chengdu Kanghong Pharmaceutical Group Co., Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
